Jan 15, 2020 / 04:30PM GMT
Viviana Limon - J.P. Morgan Securities LLC - Investment Banking Associate
Hi, good morning. My name is Viviana Limon. I'm with the JPMorgan healthcare investment banking team. Thank you all for joining us today. It's my pleasure to introduce to you, Rick Winningham, Chairman and CEO of Theravance Biopharma. He'll be presenting to you today.
Rick E. Winningham - Theravance Biopharma, Inc. - Chairman & CEO
Good morning. I'd like to thank JPMorgan for inviting us here to present today, and I look forward to just talking about Theravance and our strategy and objectives going forward.
Very simply, while you've listened to a number of companies over the week talk about the treatment for serious diseases, I don't think you'll hear another company talk about transforming the treatment of serious diseases through discovery, development and commercialization of organ-selective medicines. And I don't believe that you'll listen to another company that's actually been successful at discovering and developing, commercializing a medicine for a serious disease that
Theravance Biopharma Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot